| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |